Peri-device Leakage Closure After LAAO

Completed

Conditions studied: Atrial Fibrillation, Stroke, Bleeding, Leakage of Cardiac Device

In brief

The investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional) with different devices.

Key facts

Study ID

NCT04590898

Run by

Cardiovascular Center Frankfurt

People needed

85

Starts

2020-09-27

Expected to finish

2021-09-01

Last updated by the study team

2022-07-22

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients after interventional or surgical left atrial appendage occlusion with severe leakage, who underwent interventional peri-device leakage closure

You may not qualify if…

• n/a

Where it is running

• • Banner University Medical Center Phoenix — Phoenix, Arizona, United States
• Scripps Health — La Jolla, California, United States
• Kansas City Heart Rhythm Institute — Overland Park, Kansas, United States
• Mayo Clinic Hospital - Saint Mary's Campus — Rochester, Minnesota, United States
• Vanderbilt Heart Institute — Nashville, Tennessee, United States
• Austin Heart — Austin, Texas, United States
• University of Utah Hospital — Salt Lake City, Utah, United States
• Aarhus University Hospital — Aarhus, Denmark
• Rigshospitalet Copenhagen — Copenhagen, Denmark
• Cardio Vascular Center Frankfurt — Frankfurt am Main, Hesse, Germany
• Universitätsklinikum Düsseldorf — Düsseldorf, North Rhine-Westphalia, Germany
• Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF) — Berlin, Germany
• Poznan University of Medical Sciences — Poznan, Poland
• Hospital Universitario de Salamanca — Salamanca, Spain
• Inselspital Bern — Bern, Switzerland
• Nuffield Health — Headington, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.